FDA Investigator George G Calafactor

George G Calafactor has conducted inspections on 100 sites in 5 countries as of 09 Nov 2005. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
100
Last Inspection Date:
09 Nov 2005
Investigator Role:
FDA Investigator
Redica ID:
100001452
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Germany, Netherlands, Denmark
FDA Investigators that have inspected at least one site in common with George G Calafactor:
Alexandra A Carrico, Althea A Williams, Amber M Capello Jones, Amina Bashir, Amy S Graf, Andrew J Garufi, Anthony R Petriella, Art O Czabaniuk, Ashley A Mutawakkil, Barbara Janine Breithaupt, Benjamin J Dastoli, Benjamin J Smith, Bernard P Heidt, Bleta Vuniqi, Bonita S Chester, Brent T Hall, Brian J Mundo, Brian M Campbell, Brian P Putz, Brittany A Mckenzie, Bryan J Love, Byungja E Marciante, Calvin K Cook, Candace S Tucker, Caroline H Le, CDR Sean T Creighton, Charles E Frelix, Charles L Zhou, Charles M Spyr, Cheryl A Clausen, Christi L Bellmore, Christina L Bigham, Christine E Kelley, Clifford F Long, Constantin Y Philopoulos, Cynthia L Aycock, Cynthia Li, Danny Tuntevski, Darren S Morgan, David A Paterson, David J Gasparovich, David L Wilson, David P Vanhouten, Dawn C Olenjack, Debara R Reese, Dennis R Downer, Dennis R Hock, Dolores Harper, Donald W Myrick, Edward D Mcdonald, Elizabeth J Rigoni, Elizabeth P Kinsella, Ellen J Tave, Emest F Bizjak, Emily J Orban, Eric E Joneson, Eric S Pittman, Erin M Miller, Erma Zaimova, Evelyn Taha, Gary Durbiel Goldner, Grace E Mcnally, Hans T Meyers, Jacqueline S Warner, James A Lane, James D Planchon, James E Szelc, James N Rench, James W Plucinski, Jared P Stevens, Jdouglas Park, Jeffrey A Sincek, Jeffrey A Sommers, Jeffrey D Meng, Jesse A Vazquez, Joan A Loreng, John N Woodall, Joseph R Strelnik, Julia A Avery, K Gonzlez, Kaarin M Slotte, Kathleen M Adams, Kathryn G Brown, Kathryn M Blackshear, Kayla D Smith, Kelley L Clark, Kimberly Lewandowski Walker, Kinh Q Mac, Kristina Nastovski, Larry K Austin, Latoya A Griffith, Lauren E Burke, Lauren E Sexton, Lauren R Collins, LCDR Anastasia M Piliafas Brown, Leslie A Paul, Lillie D Witcher, Linda S Jozefiak, Lori S Lawless, Maribeth G Grattan, Maribeth G Niesen, Martha Sullivan Myrick, Meisha R Sampson, Meisha Waters, Melina Lrodriguez Upton, Michael A Moutray, Micmarie Ramos Rodriguez, Monica Cburgos Garcia, Msdap Gonzlezk, Myra K Casey, Neal D Singletary, PhD, Olalere D Fasipe, Patrick B Cummings, Paul E Stein, Perry H Gambrell, Peyton B Greenwood, Phillip M Pontikos, Pratik S Upadhyay, DDC, Rachael L Cook, Rachel T Evans, Rasha Bamieh, Rebecca E Dombrowski, Richard Jay Tucker, RS, Richard K Vogel, Richard L Rutherford, Robert M Barbosa, Rodney D Combs, Rosanna M Goodrich, Roshni J Patel, Rterry Bolen, Ryan J Benedict, Sanket N Patel, Sargum C Sood, Scott R Izyk, Shana L Williams, Shannon A Gregory, Sherri J Jackson, Stephen J Rabe, Sumit Sen, Suyang Qin, Theodore N Sietsema, Thomas A Peter, Tonnie L Carter, Tracey L Siebesma, Tracy R Ball, Travis S Bradley, Twana R Chandler, Vesa Vuniqi, Victoria A Murray, Wanda B Coats, Wenzheng Wendy Zhang, William D Tingley, William G Nelson, William R Brubaker, Yehualashet A Gessesse

George G Calafactor's Documents

Publish Date Document Type Title
June, 2001 EIR Ascensia Diabetes Care US, Inc. - EIR, 2001-06-15
November, 2002 FDA 483 Ascensia Diabetes Care US, Inc. - Form 483, 2002-11-20
March, 2000 EIR Ascensia Diabetes Care US, Inc. - EIR, 2000-03-31
June, 2003 FDA 483 Response HL Lyons Co - Form 483R, 2004-12-17
March, 2000 FDA 483 Response Ascensia Diabetes Care US, Inc. - Form 483R, 2000-04-28
September, 2003 FDA 483 Response Applied Laboratories, Inc. - Form 483R, 2003-10-01
June, 2003 FDA 483 HL Lyons Co - Form 483, 2003-06-26
September, 2004 FDA 483 Masterbilt Incorporated - Form 483, 2004-09-21
November, 2000 EIR Cantor & Nissel Ltd. - EIR, 2000-11-09
January, 2001 EIR Ascensia Diabetes Care US, Inc. - EIR, 2001-01-10
June, 2003 FDA 483 Med-Dyne, Inc. - Form 483, 2003-06-19
September, 2003 EIR Applied Laboratories, Inc. - EIR, 2003-09-30
March, 2000 FDA 483 Ascensia Diabetes Care US, Inc. - Form 483, 2000-03-31
September, 2003 FDA 483 Applied Laboratories, Inc. - Form 483, 2003-09-30
May, 2000 EIR Ascensia Diabetes Care US, Inc. - EIR, 2000-05-30

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more